European studies of interleukin-2 in metastatic renal cell carcinoma

Semin Oncol. 1993 Dec;20(6 Suppl 9):22-6.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Meta-Analysis

MeSH terms

  • Adult
  • Aged
  • Ambulatory Care
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Renal Cell / secondary
  • Carcinoma, Renal Cell / therapy*
  • Chemotherapy, Adjuvant
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Immunotherapy / methods
  • Interferon Type I / administration & dosage
  • Interferon Type I / therapeutic use*
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / analogs & derivatives*
  • Interleukin-2 / therapeutic use
  • Kidney Neoplasms / therapy*
  • Male
  • Middle Aged
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use

Substances

  • Interferon Type I
  • Interleukin-2
  • Recombinant Proteins
  • aldesleukin
  • Fluorouracil